angiotensin II receptor antagonists (Pfizer)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameangiotensin II receptor antagonists (Pfizer)
Drug Alias NameA II antagonist (Pfizer)antihypertensive (Pfizer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II receptor antagonists
TargetsAngiotensin II receptor
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesParke-Davis Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesParke-Davis CorpPfizer Inc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A